A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness

NCT06803654 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

578

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Redness

Interventions

DRUG: BTOS-HA
DRUG: Lumify®

Sponsor

Bausch & Lomb Incorporated